Advanced PET scans reveal that late-life depression and bipolar disorder may signal early neurodegenerative changes before dementia symptoms emerge.
Key Details
- 1Study involved 52 late-life mood disorder (LLMD) patients and 47 controls using PET imaging for tau and amyloid proteins.
- 2~50% of LLMD patients showed abnormal tau accumulation vs. 15% of controls; 29% had amyloid vs. 2% of controls.
- 3Autopsy of 208 brain cases confirmed higher tau-related pathologies in those with late-life mood symptoms.
- 4Pathological protein buildup detectable an average of 7.3 years before cognitive or motor symptoms.
- 5Study used two PET tracers to capture diverse tau and amyloid pathologies.
- 6Findings support tau-PET as a tool for early detection of neurodegenerative diseases in psychiatric populations.
Why It Matters
These findings advance the role of molecular PET imaging in diagnosing neurodegenerative diseases at the preclinical stage—especially in patients with mood disorders—enabling earlier interventions and reshaping the clinical approach to late-onset psychiatric presentations.
Source
EurekAlert
Related News
•EurekAlert
Deep Learning AI Outperforms Clinic Prognostics for Colorectal Cancer Recurrence
A new deep learning model using histopathology images identifies recurrence risk in stage II colorectal cancer more effectively than standard clinical predictors.
•EurekAlert
AI Reveals Key Health System Levers for Cancer Outcomes Globally
AI-based analysis identifies the most impactful policy and resource factors for improving cancer survival across 185 countries.
•EurekAlert
Dual-Branch Graph Attention Network Predicts ECT Success in Teen Depression
Researchers developed a dual-branch graph attention network that uses structural and functional MRI data to accurately predict individual responses to electroconvulsive therapy in adolescents with major depressive disorder.